Effect of celecoxib on the antihypertensive effect of losartan in a rat model of renovascular hypertension

Canadian Journal of Physiology and Pharmacology

Volumn 89, Issue 2, 2011, Pages 103-107

  Boshra, Vivian ^a   El Wakeel, Gehan Abdel Hamid ^a   Nader, Manar A ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Celecoxib; Losartan; Map; Pge2; Pra; Rvh

Indexed keywords

CELECOXIB; LOSARTAN POTASSIUM; PROSTAGLANDIN E2; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; AORTA COARCTATION; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PARTIAL SUBDIAPHRAGMATIC AORTA CONSTRICTION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; RAT; RENOVASCULAR HYPERTENSION;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; DRUG INTERACTIONS; HYPERTENSION, RENOVASCULAR; LOSARTAN; MALE; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RENIN; SULFONAMIDES;

EID: 79953116470     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y10-112     Document Type: Article

References (31)

1. Aw, T.-J., Haas, S.J., Liew, D., and Krum, H. 2005. Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure. Arch. Intern. Med. 165(5): 490-496. doi:10.1001/archinte. 165.5.IOI50013. PMID:15710786.
2. Cervenka, L., Wang, C.-T., and Navar, L.G. 1998. Effects of acute AT1 receptor blockade by candesartan on arterial pressure and renal function in rats. Am. J. Physiol. Renal Physiol. 274: 940-945.
3. Cheng, H.-F., and Harris, R.C. 2004. Cyclooxygenases, the kidney, and hypertension. Hypertension, 43(3): 525-530. doi:10.1161/01.HYP.0000116221.27079.ea. PMID:14732722.
4. Cheng, H.-F., Wang, J.-L., Zhang, M.-Z., Miyazaki, Y., Ichikawa, I., McKanna, J.A., and Harris, R.C. 1999. Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. J. Clin. Invest. 103(7): 953-961. doi:10.1172/JCI5505. PMID:10194467.
5. Collister, J.P., Hornfeldt, B.J., and Osborn, J.W. 1996. Hypotensive response to losartan in normal rats. Role of Ang II and the area postrema. Hypertension, 27(3 Pt 2): 598-606. PMID:8613210.
6. Frölich, J.C., Wilson, T.W., Sweetman, B.J., Smigel, M., Nies, A.S., Carr, K., et al. 1975. Urinary prostaglandins. Identification and origin. J. Clin. Invest. 55(4): 763-770. doi:10.1172/JCI107987. PMID:1120781.
7. Fyhrquist, F., Soveri, P., Puutula, L., and Stenman, U.H. 1976. Radioimmunoassay of plasma renin activity. Clin. Chem. 22(2): 250-256. PMID:2393.
8. Goldberg, M.R., Bradstreet, T.E., McWilliams, E.J., Tanaka, W.K., Lipert, S., Bjornsson, T.D., et al. 1995. Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients. Hypertension, 25(1): 37-46. PMID:7843751.
9. Harding, P., Sigmon, D.H., Alfie, M.E., Huang, P.L., Fishman, M.C., Beierwaltes, W.H., and Carretero, O.A. 1997. Cyclooxy-genase-2 mediates increased renal renin content induced by low-sodium diet. Hypertension, 29(1 Pt 2): 297-302. PMID: 9039118.
10. Hartner, A., Goppelt-Struebe, M., and Hilgers, K.F. 1998. Coordinate expression of cyclooxygenase-2 and renin in the rat kidney in renovascular hypertension. Hypertension, 31(1 Pt 2): 201-205. PMID:9453303.
11. Höcherl, K., Endemann, D., Kammerl, M.C., Grobecker, H.F., and Kurtz, A. 2002. Cyclo-oxygenase-2 inhibition increases blood pressure in rats. Br. J. Pharmacol. 136(8): 1117-1126. doi:10. 1038/sj.bjp.0704821. PMID:12163344.
12. Jackson, E.K., Oates, J.A., and Branch, R.A. 1981. Indomethacin decreases arterial blood pressure and plasma renin activity in rats with aortic ligation. Circ. Res. 49(1): 180-185. PMID: 7016365.
13. Kammerl, M.C., Richthammer, W., Kurtz, A., and Krämer, B.K. 2002. Angiotensin II feedback is a regulator of renocortical re-nin, COX-2, and nNOS expression. Am. J. Physiol. Regul. In-tegr. Comp. Physiol. 282(6): R1613-R1617. PMID:12010742.
14. Knights, K.M., Mangoni, A.A., and Miners, J.O. 2006. Non-selective nonsteroidal anti-inflammatory drugs and cardiovascular events: Is aldosterone the silent partner in crime? Br. J. Clin. Pharmacol. 61(6): 738-740. doi:10.1111/j.1365-2125.2006. 02678.x. PMID:16722838.
15. Mitchell, K.D., and Mullins, J.J. 1995. ANG II dependence of tubu-loglomerular feedback responsiveness in hypertensive ren-2 transgenic rats. Am. J. Physiol. 37: F821-F828.
16. O'Connor, J.P. 2003. Cox-2 inhibitors and fracture healing: Arguments for such an effect and a suggestion about caution in use. J. Bone Miner. Res. 18(3): 585-587. doi:10.1359/jbmr.2003.18. 3.585.
17. Qi, Z., Hao, C.M., Langenbach, R.I., Breyer, R.M., Redha, R., Morrow, J.D., and Breyer, M.D. 2002. Opposite effects of cy-clooxygenase-1 and-2 activity on the pressor response to angio-tensin II. J. Clin. Invest. 110(1): 61-69. PMID:12093889.
18. Schricker, K., Hamann, M., and Kurtz, A. 1995. Prostaglandins are involved in the stimulation of renin gene expression in 2 kidney-1 clip rats. Pflugers Arch. 430(2): 188-194. doi:10.1007/BF00374649. PMID:7675628.
19. Solomon, D.H., Schneeweiss, S., Levin, R., and Avorn, J. 2004. Relationship between COX-2 specific inhibitors and hypertension. Hypertension, 44(2): 140-145. doi:10.1161/01.HYP. 0000136134.31846.83. PMID:15226279.
20. Sowers, J.R., White, W.B., Pitt, B., Whelton, A., Simon, L.S., Winer, N., et al. Celecoxib Rofecoxib Efficacy and Safety in Comorbidities Evaluation Trial (CRESCENT) Investigators. 2005. The effects of cyclooxygenase-2 inhibitors and nonsteroi-dal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. Arch. Intern. Med. 165(2): 161-168. doi:10.1001/archinte.165.2.161. PMID:15668361.
21. Traynor, T.R., Smart, A., Briggs, J.P., and Schnermann, J. 1999. Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2. Am. J. Physiol. Renal Physiol. 277: F706-F710.
22. Tybitanclová, K., Szabová, L., Grima, M., Ingert, C., Zelezná, B., and Zórad, S. 2006. Blockade of AT1 receptors by losartan did not affect renin gene expression in kidney medulla. Gen. Phy-siol. Biophys. 25(1): 43-51. PMID:16714774.
23. Wang, J.L., Cheng, H.F., and Harris, R.C. 1999. Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. Hypertension, 34(1): 96-101. PMID:10406830.
24. Whelton, A., Schulman, G., Wallemark, C., Drower, E.J., Isakson, P.C., Verburg, K.M., and Geis, G.S. 2000. Effects of celecoxib and naproxen on renal function in the elderly. Arch. Intern. Med. 160(10): 1465-1470. doi:10.1001/archinte.160.10.1465. PMID:10826459.
25. Whelton, A., White, W.B., Bello, A.E., Puma, J.A., and Fort, J.G.; SUCCESS-VII Investigators. 2002. Effects of celecoxib and ro-fecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis. Am. J. Car-diol. 90(9): 959-963. doi:10.1016/S0002-9149(02)02661-9. PMID:12398962.
26. White, W.B. 2007. Cardiovascular effects of the cyclooxygenase inhibitors. Hypertension, 49(3): 408-418. doi:10.1161/01.HYP. 0000258106.74139.25. PMID:17261646.
27. Winner, L.K., Elliot, D.J., Miners, J.O., and Knights, K.M. 2005. In vitro glucoronidation of aldosterone by human liver and kidney cortical microsomes and recombinant UDP-glucuronosyltransfer-ase (UCT) 287: inhibition by non-steroidal anti-inflammatory drugs (NSAIDs). Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxi-col. 11: abstract2-02.
28. Wixson, S.K., White, W.J., Hughes, H.C., Jr., Lang, C.M., and Marshall, W.K. 1987. A comparison of pentobarbital, fentanyl-droperidol, ketamine-xylazine and ketamine-diazepam anesthesia in adult male rats. Lab. Anim. Sci. 37(6): 726-730. PMID: 3437748.
29. Wu, R., Laplante, M.-A., and de Champlain, J. 2005. Cyclooxygen-ase-2 inhibitors attenuate angiotensin II-induced oxidative stress, hypertension, and cardiac hypertrophy in rats. Hypertension, 45(6): 1139-1144. doi:10.1161/01.HYP.0000164572.92049.29. PMID:15851630.
30. Yang, T., Singh, I., Pham, H., Sun, D., Smart, A., Schnermann, J.B., and Briggs, J.P. 1998. Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am. J. Physiol. 274(3 Pt 2): F481-F489. PMID:9530264.
31. Zewde, T., and Mattson, D.L. 2004. Inhibition of cyclooxygenase-2 in the rat renal medulla leads to sodium-sensitive hypertension. Hypertension, 44(4): 424-428. doi:10.1161/01.HYP. 0000140924.91479.03. PMID:15314032.